2011 Annual Meeting | Global Health Challenges: Neurology in Developing Countries
06:30 AM - 07:10 AM |
Pharmacoeconomics and Vaccinations
Gregory D. Cascino, MD, FAAN |
|
06:30 AM - 08:30 AM |
Break
|
|
07:10 AM - 07:50 AM |
Nervous System Infections in Developing Countries
Allen J. Aksamit, Jr., MD, FAAN |
|
07:50 AM - 08:30 AM |
The World Health Organization in Developing Countries
Farrah J. Mateen, MD, PhD, FAAN |
Allen J. Aksamit, Jr., MD, FAAN | Dr. Aksamit has nothing to disclose. |
Gregory D. Cascino, MD, FAAN | Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. |
Farrah J. Mateen, MD, PhD, FAAN | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |